UnitedHealth Group Net Worth
UnitedHealth Group Net Worth Breakdown | UNH |
UnitedHealth Group Net Worth Analysis
UnitedHealth Group's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including UnitedHealth Group's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of UnitedHealth Group's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform UnitedHealth Group's net worth analysis. One common approach is to calculate UnitedHealth Group's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares UnitedHealth Group's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing UnitedHealth Group's net worth. This approach calculates the present value of UnitedHealth Group's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of UnitedHealth Group's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate UnitedHealth Group's net worth. This involves comparing UnitedHealth Group's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into UnitedHealth Group's net worth relative to its peers.
Enterprise Value |
|
To determine if UnitedHealth Group is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding UnitedHealth Group's net worth research are outlined below:
| UnitedHealth Group generated a negative expected return over the last 90 days | |
| UnitedHealth Group Incorporated has 62.54 B in debt with debt to equity (D/E) ratio of 0.59, which is OK given its current industry classification. UnitedHealth Group has a current ratio of 0.76, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for UnitedHealth to invest in growth at high rates of return. | |
| Over 90.0% of UnitedHealth Group outstanding shares are owned by institutional investors | |
| On 17th of December 2024 UnitedHealth Group paid $ 2.1 per share dividend to its current shareholders | |
| Latest headline from news.google.com: UnitedHealth Group Incorporated Shares Sold by Hantz Financial Services Inc. - MarketBeat |
UnitedHealth Group Quarterly Good Will |
|
UnitedHealth Group uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in UnitedHealth Group Incorporated. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to UnitedHealth Group's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of April 2024 Upcoming Quarterly Report | View | |
| 12th of July 2024 Next Financial Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View | |
| 10th of January 2025 Next Fiscal Year End | View | |
| 31st of December 2023 Last Quarter Report | View | |
| 31st of December 2023 Last Financial Announcement | View |
UnitedHealth Group Target Price Consensus
UnitedHealth target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. UnitedHealth Group's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 27 | Strong Buy |
Most UnitedHealth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand UnitedHealth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of UnitedHealth Group, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationUnitedHealth Group Target Price Projection
UnitedHealth Group's current and average target prices are 542.49 and 636.78, respectively. The current price of UnitedHealth Group is the price at which UnitedHealth Group Incorporated is currently trading. On the other hand, UnitedHealth Group's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
UnitedHealth Group Market Quote on 1st of February 2025
Target Price
Analyst Consensus On UnitedHealth Group Target Price
Know UnitedHealth Group's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as UnitedHealth Group is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading UnitedHealth Group Incorporated backward and forwards among themselves. UnitedHealth Group's institutional investor refers to the entity that pools money to purchase UnitedHealth Group's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Capital Research & Mgmt Co - Division 3 | 2024-09-30 | 14.7 M | Norges Bank | 2024-06-30 | 11.7 M | Northern Trust Corp | 2024-09-30 | 8.4 M | Legal & General Group Plc | 2024-09-30 | 8.3 M | Franklin Resources Inc | 2024-09-30 | 8.1 M | Royal Bank Of Canada | 2024-09-30 | 8 M | Wells Fargo & Co | 2024-09-30 | 7.9 M | Alliancebernstein L.p. | 2024-09-30 | 7.9 M | Bank Of New York Mellon Corp | 2024-09-30 | 7.9 M | Vanguard Group Inc | 2024-09-30 | 85 M | Blackrock Inc | 2024-09-30 | 73.6 M |
Follow UnitedHealth Group's market capitalization trends
The company currently falls under 'Mega-Cap' category with a total capitalization of 502.08 B.Market Cap |
|
Project UnitedHealth Group's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.13 | 0.09 | |
| Return On Capital Employed | 0.21 | 0.22 | |
| Return On Assets | 0.07 | 0.06 | |
| Return On Equity | 0.23 | 0.24 |
When accessing UnitedHealth Group's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures UnitedHealth Group's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of UnitedHealth Group's profitability and make more informed investment decisions.
Evaluate UnitedHealth Group's management efficiency
UnitedHealth Group has Return on Asset of 0.0692 % which means that on every $100 spent on assets, it made $0.0692 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1525 %, implying that it generated $0.1525 on every 100 dollars invested. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities. As of now, UnitedHealth Group's Return On Capital Employed is increasing as compared to previous years. The UnitedHealth Group's current Return On Equity is estimated to increase to 0.24, while Return On Tangible Assets are projected to decrease to 0.09. As of now, UnitedHealth Group's Total Current Assets are increasing as compared to previous years. The UnitedHealth Group's current Intangible Assets is estimated to increase to about 18.3 B, while Other Current Assets are projected to decrease to under 6.2 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 95.93 | 100.73 | |
| Tangible Book Value Per Share | (24.79) | (23.55) | |
| Enterprise Value Over EBITDA | 18.59 | 13.13 | |
| Price Book Value Ratio | 4.95 | 3.19 | |
| Price Fair Value | 4.95 | 3.19 | |
| Enterprise Value Multiple | 18.59 | 13.13 | |
| Enterprise Value | 476.5 B | 500.3 B |
Leadership effectiveness at UnitedHealth Group Incorporated is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Enterprise Value Revenue 1.3565 | Revenue | Quarterly Revenue Growth 0.092 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific UnitedHealth Group insiders, such as employees or executives, is commonly permitted as long as it does not rely on UnitedHealth Group's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases UnitedHealth Group insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Noel Timothy John over a week ago Insider Trading | ||
Cianfrocco Heather over three months ago Disposition of 10712 shares by Cianfrocco Heather of UnitedHealth Group at 327.64 subject to Rule 16b-3 | ||
Andrew Witty over a year ago Payment of 372 shares by Andrew Witty of UnitedHealth Group subject to Rule 16b-3 | ||
Andrew Witty over a year ago Acquisition by Andrew Witty of 100 shares of UnitedHealth Group subject to Rule 16b-3 |
UnitedHealth Group Corporate Filings
F4 | 22nd of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 16th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 4th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
FWP | 24th of July 2024 A written communication used by offering participants to offer securities to the public or to solicit securities transactions. | ViewVerify |
UnitedHealth Group Earnings Estimation Breakdown
The calculation of UnitedHealth Group's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of UnitedHealth Group is estimated to be 7.295 with the future projection ranging from a low of 5.89 to a high of 7.907. Please be aware that this consensus of annual earnings estimates for UnitedHealth Group Incorporated is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
5.89 Lowest | Expected EPS | 7.91 Highest |
UnitedHealth Group Earnings Projection Consensus
Suppose the current estimates of UnitedHealth Group's value are higher than the current market price of the UnitedHealth Group stock. In this case, investors may conclude that UnitedHealth Group is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and UnitedHealth Group's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 27 | 96.34% | 6.81 | 7.295 | 15.49 |
UnitedHealth Group Earnings per Share Projection vs Actual
Actual Earning per Share of UnitedHealth Group refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering UnitedHealth Group Incorporated predict the company's earnings will be in the future. The higher the earnings per share of UnitedHealth Group, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.UnitedHealth Group Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as UnitedHealth Group, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of UnitedHealth Group should always be considered in relation to other companies to make a more educated investment decision.UnitedHealth Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact UnitedHealth Group's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-01-16 | 2024-12-31 | 6.7373 | 6.81 | 0.0727 | 1 | ||
2024-10-15 | 2024-09-30 | 7 | 7.15 | 0.15 | 2 | ||
2024-07-16 | 2024-06-30 | 6.66 | 6.8 | 0.14 | 2 | ||
2024-04-16 | 2024-03-31 | 6.61 | 7.16 | 0.55 | 8 | ||
2024-01-12 | 2023-12-31 | 5.98 | 6.16 | 0.18 | 3 | ||
2023-10-13 | 2023-09-30 | 6.32 | 6.56 | 0.24 | 3 | ||
2023-07-14 | 2023-06-30 | 5.99 | 6.14 | 0.15 | 2 | ||
2023-04-14 | 2023-03-31 | 6.13 | 6.26 | 0.13 | 2 | ||
2023-01-13 | 2022-12-31 | 5.17 | 5.34 | 0.17 | 3 | ||
2022-10-14 | 2022-09-30 | 5.42 | 5.79 | 0.37 | 6 | ||
2022-07-15 | 2022-06-30 | 5.2 | 5.57 | 0.37 | 7 | ||
2022-04-14 | 2022-03-31 | 5.38 | 5.49 | 0.11 | 2 | ||
2022-01-19 | 2021-12-31 | 4.31 | 4.48 | 0.17 | 3 | ||
2021-10-14 | 2021-09-30 | 4.41 | 4.52 | 0.11 | 2 | ||
2021-07-15 | 2021-06-30 | 4.43 | 4.7 | 0.27 | 6 | ||
2021-04-15 | 2021-03-31 | 4.38 | 5.31 | 0.93 | 21 | ||
2021-01-20 | 2020-12-31 | 2.41 | 2.52 | 0.11 | 4 | ||
2020-10-14 | 2020-09-30 | 3.09 | 3.51 | 0.42 | 13 | ||
2020-07-15 | 2020-06-30 | 5.28 | 7.12 | 1.84 | 34 | ||
2020-04-15 | 2020-03-31 | 3.63 | 3.72 | 0.09 | 2 | ||
2020-01-15 | 2019-12-31 | 3.77 | 3.9 | 0.13 | 3 | ||
2019-10-15 | 2019-09-30 | 3.75 | 3.88 | 0.13 | 3 | ||
2019-07-18 | 2019-06-30 | 3.45 | 3.6 | 0.15 | 4 | ||
2019-04-16 | 2019-03-31 | 3.6 | 3.73 | 0.13 | 3 | ||
2019-01-15 | 2018-12-31 | 3.21 | 3.28 | 0.07 | 2 | ||
2018-10-16 | 2018-09-30 | 3.29 | 3.41 | 0.12 | 3 | ||
2018-07-17 | 2018-06-30 | 3.04 | 3.14 | 0.1 | 3 | ||
2018-04-17 | 2018-03-31 | 2.89 | 3.04 | 0.15 | 5 | ||
2018-01-16 | 2017-12-31 | 2.51 | 2.59 | 0.08 | 3 | ||
2017-10-17 | 2017-09-30 | 2.56 | 2.66 | 0.1 | 3 | ||
2017-07-18 | 2017-06-30 | 2.38 | 2.46 | 0.08 | 3 | ||
2017-04-18 | 2017-03-31 | 2.17 | 2.37 | 0.2 | 9 | ||
2017-01-17 | 2016-12-31 | 2.07 | 2.11 | 0.04 | 1 | ||
2016-10-18 | 2016-09-30 | 2.08 | 2.17 | 0.09 | 4 | ||
2016-07-19 | 2016-06-30 | 1.89 | 1.96 | 0.07 | 3 | ||
2016-04-19 | 2016-03-31 | 1.72 | 1.75 | 0.03 | 1 | ||
2016-01-19 | 2015-12-31 | 1.38 | 1.4 | 0.02 | 1 | ||
2015-10-15 | 2015-09-30 | 1.64 | 1.65 | 0.01 | 0 | ||
2015-07-16 | 2015-06-30 | 1.58 | 1.64 | 0.06 | 3 | ||
2015-04-16 | 2015-03-31 | 1.35 | 1.46 | 0.11 | 8 | ||
2015-01-21 | 2014-12-31 | 1.5 | 1.55 | 0.05 | 3 | ||
2014-10-16 | 2014-09-30 | 1.53 | 1.63 | 0.1 | 6 | ||
2014-07-17 | 2014-06-30 | 1.26 | 1.42 | 0.16 | 12 | ||
2014-04-17 | 2014-03-31 | 1.09 | 1.1 | 0.01 | 0 | ||
2014-01-16 | 2013-12-31 | 1.4 | 1.41 | 0.01 | 0 | ||
2013-10-17 | 2013-09-30 | 1.53 | 1.53 | 0.0 | 0 | ||
2013-07-18 | 2013-06-30 | 1.25 | 1.4 | 0.15 | 12 | ||
2013-04-18 | 2013-03-31 | 1.14 | 1.16 | 0.02 | 1 | ||
2013-01-17 | 2012-12-31 | 1.19 | 1.2 | 0.01 | 0 | ||
2012-10-16 | 2012-09-30 | 1.35 | 1.5 | 0.15 | 11 | ||
2012-07-19 | 2012-06-30 | 1.19 | 1.27 | 0.08 | 6 | ||
2012-04-19 | 2012-03-31 | 1.17 | 1.31 | 0.14 | 11 | ||
2012-01-19 | 2011-12-31 | 1.04 | 1.17 | 0.13 | 12 | ||
2011-10-18 | 2011-09-30 | 1.12 | 1.17 | 0.05 | 4 | ||
2011-07-19 | 2011-06-30 | 0.94 | 1.16 | 0.22 | 23 | ||
2011-04-21 | 2011-03-31 | 0.89 | 1.22 | 0.33 | 37 | ||
2011-01-20 | 2010-12-31 | 0.84 | 1.05 | 0.21 | 25 | ||
2010-10-19 | 2010-09-30 | 0.84 | 1.14 | 0.3 | 35 | ||
2010-07-20 | 2010-06-30 | 0.75 | 0.99 | 0.24 | 32 | ||
2010-04-20 | 2010-03-31 | 0.69 | 1.03 | 0.34 | 49 | ||
2010-01-21 | 2009-12-31 | 0.73 | 0.81 | 0.08 | 10 | ||
2009-10-20 | 2009-09-30 | 0.76 | 0.89 | 0.13 | 17 | ||
2009-07-21 | 2009-06-30 | 0.7 | 0.73 | 0.03 | 4 | ||
2009-04-21 | 2009-03-31 | 0.68 | 0.81 | 0.13 | 19 | ||
2009-01-22 | 2008-12-31 | 0.78 | 0.78 | 0.0 | 0 | ||
2008-10-16 | 2008-09-30 | 0.73 | 0.73 | 0.0 | 0 | ||
2008-07-22 | 2008-06-30 | 0.64 | 0.67 | 0.03 | 4 | ||
2008-04-22 | 2008-03-31 | 0.8 | 0.78 | -0.02 | 2 | ||
2008-01-22 | 2007-12-31 | 0.92 | 0.92 | 0.0 | 0 | ||
2007-10-18 | 2007-09-30 | 0.92 | 0.95 | 0.03 | 3 | ||
2007-07-19 | 2007-06-30 | 0.81 | 0.87 | 0.06 | 7 | ||
2007-04-19 | 2007-03-31 | 0.71 | 0.74 | 0.03 | 4 | ||
2007-01-18 | 2006-12-31 | 0.85 | 0.86 | 0.01 | 1 | ||
2006-10-19 | 2006-09-30 | 0.76 | 0.79 | 0.03 | 3 | ||
2006-07-19 | 2006-06-30 | 0.68 | 0.7 | 0.02 | 2 | ||
2006-04-18 | 2006-03-31 | 0.64 | 0.63 | -0.01 | 1 | ||
2006-01-19 | 2005-12-31 | 0.66 | 0.65 | -0.01 | 1 | ||
2005-10-14 | 2005-09-30 | 0.63 | 0.64 | 0.01 | 1 | ||
2005-07-14 | 2005-06-30 | 0.6 | 0.61 | 0.01 | 1 | ||
2005-04-14 | 2005-03-31 | 0.56 | 0.58 | 0.02 | 3 | ||
2005-01-20 | 2004-12-31 | 0.54 | 0.55 | 0.01 | 1 | ||
2004-10-14 | 2004-09-30 | 0.5 | 0.52 | 0.02 | 4 | ||
2004-07-15 | 2004-06-30 | 0.46 | 0.47 | 0.01 | 2 | ||
2004-04-15 | 2004-03-31 | 0.43 | 0.44 | 0.01 | 2 | ||
2004-01-22 | 2003-12-31 | 0.4 | 0.42 | 0.02 | 5 | ||
2003-10-16 | 2003-09-30 | 0.37 | 0.39 | 0.02 | 5 | ||
2003-07-17 | 2003-06-30 | 0.33 | 0.36 | 0.03 | 9 | ||
2003-04-16 | 2003-03-31 | 0.31 | 0.32 | 0.01 | 3 | ||
2003-01-23 | 2002-12-31 | 0.29 | 0.3 | 0.01 | 3 | ||
2002-10-17 | 2002-09-30 | 0.26 | 0.28 | 0.02 | 7 | ||
2002-07-18 | 2002-06-30 | 0.24 | 0.25 | 0.01 | 4 | ||
2002-04-18 | 2002-03-31 | 0.21 | 0.23 | 0.02 | 9 | ||
2002-01-24 | 2001-12-31 | 0.18 | 0.19 | 0.01 | 5 | ||
2001-10-26 | 2001-09-30 | 0.17 | 0.18 | 0.01 | 5 | ||
2001-07-27 | 2001-06-30 | 0.16 | 0.17 | 0.01 | 6 | ||
2001-04-27 | 2001-03-31 | 0.15 | 0.16 | 0.01 | 6 | ||
2001-02-02 | 2000-12-31 | 0.14 | 0.14 | 0.0 | 0 | ||
2000-10-27 | 2000-09-30 | 0.12 | 0.14 | 0.02 | 16 | ||
2000-08-04 | 2000-06-30 | 0.12 | 0.13 | 0.01 | 8 | ||
2000-05-04 | 2000-03-31 | 0.11 | 0.12 | 0.01 | 9 | ||
2000-02-10 | 1999-12-31 | 0.1 | 0.11 | 0.01 | 10 | ||
1999-11-03 | 1999-09-30 | 0.1 | 0.1 | 0.0 | 0 | ||
1999-08-05 | 1999-06-30 | 0.09 | 0.1 | 0.01 | 11 | ||
1999-05-06 | 1999-03-31 | 0.09 | 0.09 | 0.0 | 0 | ||
1999-02-18 | 1998-12-31 | 0.08 | 0.08 | 0.0 | 0 | ||
1998-11-05 | 1998-09-30 | 0.08 | 0.08 | 0.0 | 0 | ||
1998-08-06 | 1998-06-30 | 0.08 | 0.08 | 0.0 | 0 | ||
1998-05-07 | 1998-03-31 | 0.08 | 0.08 | 0.0 | 0 | ||
1998-02-12 | 1997-12-31 | 0.07 | 0.07 | 0.0 | 0 | ||
1997-11-06 | 1997-09-30 | 0.07 | 0.07 | 0.0 | 0 | ||
1997-08-07 | 1997-06-30 | 0.07 | 0.07 | 0.0 | 0 | ||
1997-05-08 | 1997-03-31 | 0.07 | 0.07 | 0.0 | 0 | ||
1997-02-13 | 1996-12-31 | 0.06 | 0.06 | 0.0 | 0 | ||
1996-11-07 | 1996-09-30 | 0.06 | 0.06 | 0.0 | 0 | ||
1996-08-08 | 1996-06-30 | 0.05 | 0.05 | 0.0 | 0 | ||
1996-05-07 | 1996-03-31 | 0.08 | 0.08 | 0.0 | 0 | ||
1996-02-28 | 1995-12-31 | 0.07 | 0.07 | 0.0 | 0 | ||
1995-11-01 | 1995-09-30 | 0.07 | 0.07 | 0.0 | 0 |
UnitedHealth Group Corporate Directors
| Gail Wilensky | Independent Director | Profile | |
| Valerie Rice | Independent Director | Profile | |
| John Noseworthy | Independent Director | Profile | |
| William Ballard | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.043 | Earnings Share 15.49 | Revenue Per Share | Quarterly Revenue Growth 0.092 | Return On Assets |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.